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Background. Peak oxygen uptake (VO2peak) and muscle function are more decreased in patients with a combination of chronic
heart failure (CHF) and type 2 diabetes mellitus (2DM) compared to patients with only one of the conditions. Further, patients
with 2DM have peripheral complications that hamper many types of conventional exercises. Aim.T oe v a l u a t et h ee ﬃcacy and
applicability of eight-week aquatic exercise in patients with the combination of CHF and 2DM. Methods. Twenty patients (four
women) with both CHF and 2DM (age 67.4 ± 7.1, NYHA II-III) were randomly assigned to either aquatic exercise or a control
group. The patients exercised for 45 minutes 3 times/week in 33–34◦C, swimming pool. Results. The training programme was well
tolerated. Work rate (+11.7 ± 6.6v e r s u s−6.4 ± 8.1watt,P<0.001) and VO2peak (+2.1 ± 0.8v e r s u s−0.9 ± 1.4m L ·kg−1·min−1,
P<0.001) and walking capacity (P = 0.01) increased signiﬁcantly in the training group. Muscle function was also signiﬁcantly
improved and Hba1c decreased signiﬁcantly (P<0.01) during training, while fasting glucose, insulin, c-peptide, and lipids were
unchanged . Training also increased vitality measured by SF-36 signiﬁcantly (P = 0.05). Conclusion. Aquatic exercise could be used
to improve exercise capacity and muscle function in patients with the combination of CHF and 2DM.
1.Introduction
Up to 25% of patients with chronic heart failure (CHF)
have type 2 diabetes mellitus (2DM) [1], and it could
be foreseen that this combination will be increasingly
common [2]. 2DM entails a markedly increased risk of
developingcardiovasculardiseases[3].Further,inalltypesof
cardiovasculardiseasepatientswith2DMhaveasigniﬁcantly
higher rate of mortality and morbidity than patients without
[4]. On the contrary, CHF results in an insulin resistance
syndrome which in turn could lead to the development of
2DM [5]. Both patients with CHF and 2DM, separately
or in combination, suﬀer from reduced physical function,
with decreased oxygen uptake and poor muscle function
[6, 7]. In both conditions, similar pathological consequences
are found in the skeletal muscle, such as an increased
number of type II muscle ﬁbres, low capillary density, and
decreased oxidative capacity [8, 9]. Other similarities are
signs of impaired endothelial function, which might be
important to muscle function and physical performance
[10, 11]. However, the impaired endothelial function might
be corrected by exercise training [12]. The diseases do often
impactnegativelyonactivityofdailylivingandqualityoflife.
These patients risk in a greater extent to develop depression
and anxiety in comparison with a healthy population [13,
14]. There are consistent reports of improvement in physical
performanceandpsychological functionafteraerobicand/or
resistanceexercisetraininginCHFaswellasin2DM[15,16].
Since the prevalence of both conditions increases with age
it is not unusual that patients also have other disabilities2 Evidence-Based Complementary and Alternative Medicine
that further restrain physical ability. Aquatic exercise, that
is, physical training in warm water, is an alternative exercise
regimen, and we have recently shown positive eﬀects of
aquatic exercise in patients with CHF without 2DM [17].
To conﬁrm the results of our previous study using aquatic
exercise and to assess the eﬃcacy of such training in patients
with the combination of CHF and 2DM, this study was
performed.
The hypothesis was that training in warm water would
be safe and result in improvement in physical performance,
musclefunction,andmetaboliccontrolinpatientswithCHF
and 2DM.
Therefore the aim of this study was to investigate the
eﬀect of aquatic exercise in patients with CHF and 2DM.
2. Methods
2.1. Patients. Twenty patients (four women) with stable
CHF and 2DM in NYHA class II or III, ejection fraction
(EF) <50%, age above 55 years were included. Heart failure
medication had to be stable for the previous three months.
Exclusion criteria were peripheral artery disease, chronic
pulmonary disease, status after stroke, or other disabling
diseases that might interfere with the exercise protocol. The
process of patient recruitment is described in Figure 1.A f t e r
baseline testing, patients were randomised, using a 1:1 ratio,
inastratiﬁedaccordingtoorderto8weeksofaquaticexercise
(n = 1 0 ) ,o rt oac o n t r o lp e r i o d( n = 10). The patients were
stratiﬁed according to age, NYHA class and gender. Baseline
characteristics of the study population are given in Table 1.
The study complied with the Declaration of Helsinki. The
Ethics committee of Gothenburg University approved the
research protocol, and informed consent was obtained from
eachsubject.Thetestingprocedureswererepeatedaftereight
weeks of training or control period, respectively.
2.2. Procedure. All patients performed the below given tests
within 10 days before the randomisation and then during the
last 10 days of the study period. Patients started on the ﬁrst
day with venous blood samples followed by an acquaintance
test on the ergospirometer. Thereafter, questionnaires were
ﬁlled out and the six-minute walk test performed. Finally
patients performed on day 4–6 the maximal test on the
ergospirometer and on day 8–10 the muscle tests.
2.3. Assessments
2.3.1. Exercise Capacity. W o r kr a t ea n dp e a ko x y g e nu p t a k e
(VO2peak)w er emeasur edonanergomet er ,usingaramppr o-
tocol with a 10-watt increase every minute until exhaustion.
Expired gas was measured breath by breath using a V-max
system (Sensor Medics, USA) as previously described [17].
2.3.2. Six-Minute Walking Test. A standardised six-minute
walking test was used to assess exercise capacity related to
activities of daily living. The patients were asked to walk as
far as possible during six minutes on a premarked 30-meter
walkway [17, 18].
Table 1: Demographic data of patients with chronic heart failure




(n = 10) P value
Age (years) 65.8 ±5.86 9 ±8.2n s
Sex (F/M) 2/82 /8n s
Weight (kg) 93.6 ±16.28 6 .6 ±24.2n s
Height (cm) 176.1 ±10 174 ±8.8n s
Duration of CHF (years) 5.3 ±2.66 .0 ±5.2n s
Duration of 2DM
(years) 7.2 ±5.86 .9 ±4.4n s
LVEF (%) 34.1 ±9.83 4 .8 ±9.1n s
Etiology of CHF
(IHD/DCM/HT) 8/1/14 /4/2n s
NYHA class (II/III) 5/53 /7n s
Chronic atrial
ﬁbrillation (n) 53 n s
Beta blockers (n)9 8 n s
ACE-inhibitors (n)89 n s
Diuretics (n)9 9 n s
Digitalis (n)2 5 n s
Insulin (n)5 3 n s
Anti diabetics (n)5 8 n s
Acetyl-salicylic acid (n)5 8 n s
Warfarin (n)5 3 n s
F/M: female and male, LVEF: left ventricular ejection fraction, NYHA: New
York Heart Association classiﬁcation, IHD: ischemic heart disease, DCM:
dilated cardiomyopathy, HT: hypertension, ACE: angiotensin converting
enzyme, n: number, ns: not signiﬁcant.
2.3.3. Muscle Strength and Endurance. For measurement of
isometric and isotonic strength and isotonic endurance the
Biodex III (Biodex medical systems, New York, USA) was
used. The test was preceded by a 5-minute warmup on a
test bicycle. The subjects sat with a hip angle of 90◦, and the
right leg was attached to the lever arm of the dynamometer.
Isometric knee extension strength was measured at a 60◦
knee angle. Isokinetic concentric strength was measured at
60◦/s and at 180◦/s for knee extensors. Isokinetic endurance
wasevaluatedasthereductionoftorque(inpercent)between
the ﬁrst and the last three extensions in a series of 50
maximal contractions with an angle of 180◦/s. Handgrip
strength, the maximum grip force, and the mean value of
the 10-second sustained grip was assessed by Grippit (AB
Detector, G¨ oteborg, Sweden). Clinical endurance tests, that
is, unilateral isotonic heel-lift, bilateral isometric shoulder
abduction and unilateral isotonic shoulder ﬂexion were
also measured. The test procedures have been described
previously [17].
2.3.4. Quality of Life. Health-related quality of life was mea-
sured using the Medical Outcome Short Form—36 (SF-36)
[19] and disease-speciﬁc quality of life with the Minnesota
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criteria (n = 401)
Received allocated intervention,
(n = 10)
-peripheral ulcer caused by new
shoes, (n = 1)
-peripheral ulcer caused by new
shoes, (n = 1)
Received allocated intervention,
(n = 10)
Figure 1: The inclusion process of patients.
anxiety and depression scale (HAD) was used to assess the
level of anxiety and depression [21].
2.3.5. Metabolic Function. Venous blood samples for assess-
ing plasma glucose, HbA1c, serum insulin, serum C-peptide,
andserumlipids weretakenbeforeandaftertheintervention
period after an overnight fast and analysed according to the
European Accreditation system [22].
2.3.6. Training Programme. The training programme com-
prised 45-minute sessions in a heated pool (33◦-34◦C), three
times a week over an eight-week period. The patients trained
as a group following a low-to-moderate exercise level, that
is, 40 to 75% of maximal heart rate reserve (HRR). The
basis posture was standing with water just below neck level.
The programme focused on peripheral muscle training but
central circulatory exercises were also included as earlier
described [17]. The control group was instructed to live their
lifeasnormalforeightweeksandwasnotallowedtoincrease
their habitual physical activity during this period.
2.3.7. Statistics. The SPSS 12.0 for Windows (Chicago, IL,
USA) was used to analyse the data.
Ratio and interval data are given as mean (±1S Do r
95% CI) and ordinal data as median and range. Wilcoxon-
matched pairs signed rank sum test was used for compar-
isons of paired observations within each study group. The
Mann Whitney U-test was used to assess diﬀerences between
groups. Nominal data between groups was compared by
Chi-squared test or Fisher’s exact test. A P value≤0.05 was
considered signiﬁcant. A per-protocol design was used on all
data.
3. Results
Aquatic exercise was well tolerated by the patients and no
adverse events occurred during the aquatic exercise. Two
patients in the training group were withdrawn, due to a
peripheral ulcer caused by new shoes, increased symptoms
of CHF, respectively. One patient in the control group was
withdrawn, due to family problems. The average adherence
(total number of attended sessions) was 92%. HRR during
training ranged between 40% and 60% during peripheral
muscle training exercises and between 55% and 75% during
the aerobic exercises. In the training group two patients
needed to reduce their insulin and one to take away the oral
antidiabetics due to hypoglycaemia.
3.1. Exercise Capacity and Muscle Function. Physical per-










































































Training group Control group
(c)
Figure 2: Work rate (a), peak oxygen uptake VO2peak (b), and distance walked (c) in six minute walk test before   (n = 10 and 10) and after
  (n = 8 and 9) eight weeks of aquatic exercise.
compared with the control group, regarding work rate,
VO2peak (P<0.001), and walking capacity (P = 0.01)
(Figure 2(a)–2(c)). There were no signiﬁcant diﬀerences
in knee extension regarding isometric strength, isotonic
strength 60◦/s, or isotonic endurance, neither in handgrip
strength or endurance. However, a signiﬁcant increase in
isokinetic strength 180◦/s (P<0.001), isotonic heel lift (P =
0.01), shoulder ﬂexion (P<0.05), and isometric shoulder
abduction (P<0.001) was found in the training group after
aquatic exercise (Table 2).
3.2. Metabolic Function. Hba1c decreased during aquatic
exercise, but there was no signiﬁcant improvement in fasting
plasma glucose, insulin, c-peptide, or blood lipids after eight
weeks of training (Table 3).
3.3. Health Related Quality of Life. Compared to a Swedish
reference population [23], our patients with CHF and 2DM
had lower SF-36 scores in all domains except for bodily
pain,Figure 3(a).Therewasasigniﬁcantdiﬀerenceinvitality
scoring after aquatic exercise, whereas other domains were
unchanged, Figure 3(b). Disease speciﬁc quality of life and
grade of anxiety was unchanged in both groups after the
intervention period, Table 4.
4. Discussion
This is the ﬁrst study to show that aquatic exercise could
be used as an eﬀective tool to improve physical function in
patients with the combination of CHF and 2DM. Further,
the study conﬁrms the results of our previous study with
warm water training in elderly patients, supporting that this
training is safe for patients with CHF.
4.1. Exercise Performance. An u m b e ro fs t u d i e sh a v ed e m o n -
strated that exercise training on land, aerobic and resistance
exercise improve function in patients with either CHF or
with 2DM [15, 16]. VO2peak is an important prognostic
marker in these patients [24, 25] and it is signiﬁcantly more
reduced in patients with a combination of 2DM and CHF,
than in patients with only one of the diseases [26]. It was
therefore an important ﬁnding in this study that aquatic
exercise was associated with a signiﬁcant improvement in
VO2peak.Improvedgeneralperformancewasalsoshownasan
increase in work rate and walking capacity. The physiologicalEvidence-Based Complementary and Alternative Medicine 5
Table 2: Muscle function before and after aquatic exercise in patients with chronic heart failure and type 2 diabetes mellitus.




P value within the
group
P value versus the control
group
Peak torque (60◦sN m )r i g h tl e g T 122 ± 41 127 ± 34 ns ns
C 102 ± 30 98 ± 32 ns
Peak torque (180◦sN m )r i g h tl e g T8 8 ± 28 119 ± 54 0.02 <0.001
C6 6 ± 22 64 ± 24 ns
Endurance decline in %, left leg T4 6 ± 17 44 ± 13 ns ns
C5 1 ± 14 52 ± 16 ns
Isometric
Peak torque T 136 ± 41 136 ± 40 ns ns
60◦ (N) right leg C 109 ± 37 101 ± 32 ns
Hand strength
Peak force (N) T 342 ± 121 385 ± 106 ns ns
Right hand C 248 ± 82 221 ± 62 0.04
Peak force 10s (N) T 289 ± 108 323 ± 89 ns ns
Right hand C 207 ± 77 187 ± 62 ns
Clinical endurance tests
Heel lift (n.o) T1 4 ± 71 8 ± 60 . 0 1 0.01
C1 4 ± 41 4 ± 5n s
Shoulder ﬂexion (n.o) T2 6 ± 11∗ 36 ± 12 0.02 0.03
C1 7 ± 81 7 ± 28 ns
Shoulder abduction (s) T7 5 ± 25 89 ± 27 0.01 <0.001
C6 4 ± 26 56 ± 22 0.03
T: Training group, C: control group, ns: not signiﬁcant, n.o.: number of, ∗: P ≤ 0.05 at baseline between training and control group.





P value within the
group
P value versus the control
group
Hba1c (%) T7 .9 ±2.97 .2 ±0.90 . 0 1 ns
C6 .9 ±2.06 .7 ±3.2n s
P-Fasting glucos (mmol/L) T1 0 .2 ±2.99 .3 ±2.6n s ns
C7 .8 ±3.36 .9 ±2.0n s
S-Insulin (mU/L) T2 0 ±5.72 0 .1 ±11.5n s ns
C1 9 .2 ±14.91 6 .1 ±14.0n s
S-C-peptide (nmol/L) T0 .8 ±0.41 .1 ±0.5n s ns
C1 .0 ±0.91 .4 ±1.5n s
S-Triglycerides (mmol/L) T2 .4 ±3.42 .2 ±2.1n s ns
C1 .9 ±1.01 .6 ±0.8n s
S-Cholesterol (mmol/L) T4 .2 ±1.04 .3 ±0.9n s ns
C4 .2 ±1.14 .1 ±0.5n s
P: plasma, S: serum, T: training group, C: control group.
reason for this improvement was not investigated, but others
have shown that exercise in the two diseases separately
results in cardiac and peripheral muscle function enhance-
ment which improves cardiac output and arteriovenous
oxygen diﬀerence. Elevated peripheral resistance and poor
endothelial function are factors that might contribute to
reduced exercise capacity; however it could be enhanced by
physical training [15, 16]. Immersion in warm water results
in immediate improvement in cardiac function, probably
mediated by peripheral vasodilation and unloading of left
ventricular function [27, 28]. Whether such eﬀects would be



































































Figure 3:(a)ScoresofSF-36inallpatientswithchronicheartfailureandtype2diabetesmellitus, ,(n = 20)comparedtoaSwedishhealthy
reference population -♦-. (b) Change in SF-36 after aquatic exercise, training group,  ,( n = 8) control group,  ,( n = 9)
∗, P = 0.05.









Total score T4 8 ±22 43 ±15 Anxiety 5.1 ±4.85 .4 ±3.7
C3 5 ±13 35 ±16 3.1 ±1.83 .5 ±3.0
Physical dimension T2 2 ±14 16 ±8 Depression 3.5 ±3.23 .6 ±2.3
C1 9 ±11 20 ±13 4.2 ±2.74 .9 ±3.7
Emotional dimension T1 0 ±87 ±6
C5 ±45 ±4
LHFQ: Minnesota living with heart failure questionnaire HAD: hospital anxiety and depression scale. T: Training group, C: control group.
training on land, would need further studies comparing the
two exercise regimens.
4.2. Muscular Performance. Isokinetic strength in knee
extensors was merely signiﬁcantly improved at 180◦/s and
not in isokinetic strength at 60◦/s or in isokinetic endurance
and isometric strength. We have previously been hypothe-
sised that an absent improvement in knee muscle function
during aquatic exercise is due to the diﬃculty to gain enough
resistanceforthislargemusclegroupinwater[17].However,
the sensitivity of the test does also have large impact of the
test results after training. Studies have shown that isotonic
knee extensor training did not result in isokinetic knee
extensor improvement [29, 30]. The increment in knee
extension at 180◦/s might be due to an enhanced neural
adaptationsincethistestmirrorstheabilitytodeveloppower
[31, 32]. It seems less likely that this improvement should be
attributable to an increase in the amount of type II ﬁbres,
after a relatively short endurance training of eight weeks.
Aquatic exercise resulted also in increased isometric and
isotonic muscle endurance measured by clinical endurance
tests. These tests were performed exactly the way as it was
trained. Speciﬁc adaptations in skeletal muscle after exercise
seem to beneﬁt patients with 2DM since the active muscle
tissue reveals a higher metabolic rate in glucose metabolism
[15]. An important ﬁnding in this study wasthat the training
maintained and improved endurance in both upper and
lower body muscle groups, which is important for older
people to prevent falls and to accomplish daily tasks of living
requiring both static and dynamic eﬀorts [33].
4.3. Metabolic Control. No speciﬁc advice concerning diet
or diabetic treatment was given during this study. Diabetic
therapy was supplied by the patient’s ordinary health care
and was not part of the study. A positive ﬁnding was the
decrease in HbA1c after training. However, other markers of
metabolic control did not change. It was not the scope of this
study to investigate insulin resistance, and others have shown
signs of decreased insulin resistance after exercise in 2DM
[34] however, the eﬀect of training is unclear in CHF [35].
We could not conﬁrm that immersion in warm water solely
could enhance metabolic function in patients with 2DM, as
shown by Hooper [36].
4.4. Quality of Life Measurements. The size of the population
in this study was inadequate to show unequivocal changes in
quality of life. Of the instruments used, only an index in SF-
36, vitality increased after aquatic exercise. Since the level of
anxiety and depression was low among most of our patients
at baseline no eﬀect was seen in HAD scores.Evidence-Based Complementary and Alternative Medicine 7
4.5.AquaticExercise. Aquaticexerciseenablesacombination
of aerobic and resistance exercises and is especially suitable
for patients with advanced age, obesity, peripheral neu-
ropathy, orthopaedic problems, or other comorbidity that
hampers exercises on land. Due to the buoyancy eﬀect in
w a t e rw e i g h tb e a r i n ga c t i v i t i e sa r em u c hm o r ee ﬀortless to
performinwater[37].Forexample,itismoreuncomplicated
for a patient with peripheral neuropathy to walk in water.
The rate of adherence in this supervised short-term
exercise study was high, which is in accordance with several
other studies in patients with CHF [17, 38, 39]a sw e l l
as with 2DM [24]. However, the long-term adherence in
nonsupervised exercise has been reported low by others
[40, 41]. A “smorgasbord” of physical training regimen to
the patient’s disposal might enhance the rate of adherence to
prescribed exercise.
4.6. Limitations. Similar to many other exercise studies in
patients with CHF, our study was performed in a limited
number of patients which may restrict external validity. A
marked diﬃculty was to recruit patients that were free from
other disabling and complicating disorders like peripheral
ulcers, infections, or problems with glycaemic control which
are more common in patients with the combination of CHF
and 2DM. Further, these patients have a higher morbidity
that increases the risk of withdrawal during the study period.
In clinical practice, these conditions might temporarily
hinder participation in training programmes. However, a
temporary stop in the programme should not exclude these
patients from the beneﬁcial eﬀects of physical training in the
long run.
5. Conclusion
Aquatic exercise is safe and eﬀective to improve physical and
metabolic function in patients with the combination of CHF
and 2DM. Whether conventional exercise on land is equally
eﬀective has not been shown and would need further studies.
Training in water is especially beneﬁcial for those patients
with other disabilities that obstruct exercises on land.
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